New Testing Approach Differentiates Normal Memory Loss from Alzheimer’s
Investigators used scores obtained from cognitive tests to determine that an uneven distribution of scores over a battery tests appears to predict Alzheimer’s.
Experts are aware that the risk of developing dementia increases markedly when a person is diagnosed with mild cognitive impairment.
However, mild cognitive impairment is a common occurrence — a condition in which a measurable decline in intellectual abilities does not seriously interfere with daily life.
Nevertheless, 5 to 10 percent of individuals with cognitive impairment will progress to dementia, and physicians do not have a reliable way to predict which people will be in this category.
In a proof-of-concept study, the Johns Hopkins investigators analyzed records of 528 people age 60 and over, who were referred to the Johns Hopkins Medical Psychology Clinic for cognitive testing as part of a dementia work-up between 1996 and 2004.
The results were compared to those of 135 healthy older adults who participated in a study of normal aging.
Both groups completed tests of memory, language, attention, processing speed and drawing abilities from which 13 scores were recorded.
Since each person is naturally more skillful in some areas than in others, the scores of healthy adults showed a symmetrical, bell-shaped range.
Thus, most of their scores were high, a few were a bit lower, and a few were even lower.
By grouping the patients into cohorts based on the severity of their dementia, the researchers found a trend in the test scores that is likely to mimic the deterioration of an individual’s scores over time.
At the outset, Alzheimer’s disease subtly disrupts some mental abilities, while leaving others intact. Therefore, well before a person develops clear cognitive impairment, his or her performance declines slightly on a few measures.
When shown on a graph, these changes cause the healthy symmetric, bell-shaped curve to shift and become asymmetrical.
Regardless of how low a person’s test scores were, the researchers determined that lopsidedness in their score distribution correlated with dementia.
They predicted that people with low scores that were evenly distributed were not likely to develop dementia. But those with clearly lopsided test score distributions on the 13 measures administered were already experiencing varying levels of dementia.
“Departures from the normal bell-shaped pattern of variability on cognitive tests might determine which people with low scores develop dementia,” said David J. Schretlen, Ph.D., a professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine.
As reported in the study, published online in the journal Neuropsychology, the decline in scores can be subtle. Thus, researchers also increased the precision of cognitive testing by accounting for the effects of age, sex, race and education on test performance.
The challenge for doctors, Schretlen said, is that most normal, healthy people will produce a few low scores on cognitive testing.
That makes it nearly impossible to know at the outset whether a patient who reports forgetfulness and produces one or two low scores has a benign form of mild cognitive impairment, or is in the earliest stage of dementia.
As a result, doctors often tell such patients to return for follow-up testing in a year or two.
But if future research confirms it, this new statistical model could help doctors get the prognosis right earlier in the disease, at the first visit, and start treating patients accordingly.
Mostly, Schretlen said, doctors could use the new model to reassure patients who are not at risk of dementia, while fast-tracking interventions for those who are.
Because there currently are no effective treatments for Alzheimer’s disease, those likely headed that way could be counseled to take the good time they have to organize their affairs, and do things they have always wanted to do.
They also could be fast-tracked into clinical trials of medications to slow the progression of dementia.
“If we are going to have any hope of helping patients with Alzheimer’s disease, we need to do it as early as possible,” Schretlen said.
“Once the brain deteriorates, there’s no coming back.”
Recent failures of drugs in late-stage clinical trials for Alzheimer’s disease have been a real blow, he said, but new treatments are being developed.
The new way of reading existing test scores follows a 2008 study by the same researchers showing that one of every six healthy adults scored poorly on two or more of 10 tests in a brief cognitive battery — even though there was nothing wrong with them.
The main reason it is difficult to tell whether older people have benign mild cognitive impairment or not is because they are not routinely screened for cognitive impairment, he says.
A visit to a specialist comes only after someone has noticed symptoms, and then cognitive testing is interpreted without the benefit of a baseline assessment.
What would solve this problem, he said, would be for everyone over the age of 55 to get routine neurocognitive testing every five years.
Source: Johns Hopkins Medicine
Nauert PhD, R. (2018). New Testing Approach Differentiates Normal Memory Loss from Alzheimer’s. Psych Central. Retrieved on December 1, 2020, from https://psychcentral.com/news/2013/11/13/new-testing-approach-differentiates-normal-memory-loss-from-alzheimers/61986.html